Health

In today’s consumer-driven world, awareness of the substances used in everyday products is crucial for public health. The presence of per- and polyfluoroalkyl substances (PFAS), commonly found in household items like dental floss, has raised alarms among health professionals. Laurel Schaider, a senior scientist at the Silent Spring Institute, emphasizes the alarming fact that consumers
0 Comments
Primary biliary cholangitis (PBC) poses a significant challenge to hepatologists and patients alike. The landmark approval of ursodeoxycholic acid (UDCA) in 1997 was heralded as a breakthrough moment in the treatment of PBC, notably reducing the necessity for liver transplants and the risk of mortality. Nevertheless, the journey toward more comprehensive management strategies for PBC
0 Comments
Mirikizumab, known commercially as Omvoh, has recently garnered attention for its effectiveness in treating patients suffering from moderately-to-severely active Crohn’s disease, particularly those who have not responded to conventional therapies. A pivotal phase III randomized controlled trial showcased its potential by demonstrating significantly improved patient outcomes compared to placebo. This article delves into the study’s
0 Comments
Psoriasis is known as an autoimmune skin condition that affects millions globally, leading to red, scaly patches on the skin. The chronic nature of this disease manifests not only physically but also impacts psychological well-being. Recent research emerging from France has unveiled a concerning correlation between the activity of psoriasis and the consumption of ultraprocessed
0 Comments
The Centers for Medicare & Medicaid Services (CMS) has recently put forth a proposed rule aimed at increasing transparency and fairness in Medicare Advantage (MA) plans. This initiative, a part of the broader efforts by the Biden administration, seeks to reform prior authorization processes, thereby allowing patients to gain better access to necessary healthcare services.
0 Comments
Meningiomas represent a significant portion of primary brain tumors, known for their diverse behavioral patterns and treatment responses. The burgeoning field of neuro-oncology has consistently sought to refine surgical techniques to improve patient outcomes. One intriguing method that has gained traction is preoperative embolization, a procedure designed to reduce blood flow to the tumor before
0 Comments
The healthcare sector often finds itself in a battleground of regulatory dilemmas, where scientific advancement intersects with the intricate web of policies and societal expectations. At a recent FDA advisory committee meeting, Donald Kohn, MD, highlighted the challenges faced while deliberating the approval status of the bleeding reversal agent andexanet alfa (Andexxa). This situation illustrates
0 Comments